$3.52 Billion is the total value of Nantahala Capital Management's 121 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 37.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IWM | Sell | ISHARES TRput | $458,740,000 | -13.5% | 2,000,000 | -16.7% | 13.03% | -15.9% |
| W | WAYFAIR INCcall | $411,686,000 | +0.3% | 1,304,000 | 0.0% | 11.70% | -2.5% | |
| TLT | Buy | ISHARES TRput | $173,220,000 | +113.1% | 1,200,000 | +100.0% | 4.92% | +107.2% |
| ESTA | Sell | ESTABLISHMENT LABS HLDGS INC | $168,327,000 | +30.7% | 1,927,264 | -6.4% | 4.78% | +27.1% |
| SGMS | Sell | SCIENTIFIC GAMES CORPcall | $120,752,000 | +52.2% | 1,559,300 | -24.3% | 3.43% | +48.0% |
| IWO | New | ISHARES TRput | $93,507,000 | – | 300,000 | +100.0% | 2.66% | – |
| CDXS | Sell | CODEXIS INC | $87,496,000 | -8.8% | 3,861,232 | -7.9% | 2.49% | -11.4% |
| QADA | Sell | QAD INCcl a | $80,646,000 | +26.2% | 926,756 | -3.4% | 2.29% | +22.6% |
| QURE | Buy | UNIQURE NVcall | $64,862,000 | +28.4% | 2,105,900 | +40.4% | 1.84% | +24.8% |
| MLHR | New | MILLER HERMAN INC | $64,406,000 | – | 1,366,266 | +100.0% | 1.83% | – |
| CVNA | CARVANA COcall | $61,481,000 | +15.0% | 203,700 | 0.0% | 1.75% | +11.8% | |
| VG | Sell | VONAGE HLDGS CORP | $61,489,000 | +12.2% | 4,267,140 | -8.0% | 1.75% | +9.1% |
| THC | TENET HEALTHCARE CORPcall | $58,676,000 | +28.8% | 875,900 | 0.0% | 1.67% | +25.2% | |
| CASH | Buy | META FINL GROUP INC | $54,373,000 | +21.5% | 1,073,936 | +8.7% | 1.54% | +18.1% |
| QURE | Buy | UNIQURE NV | $54,293,000 | -3.7% | 1,762,766 | +5.4% | 1.54% | -6.3% |
| XBI | New | SPDR SER TRput | $54,160,000 | – | 400,000 | +100.0% | 1.54% | – |
| TNL | Sell | TRAVEL PLUS LEISURE CO | $49,349,000 | -3.6% | 830,092 | -0.8% | 1.40% | -6.3% |
| IMAX | Buy | IMAX CORP | $47,117,000 | +61.4% | 2,191,490 | +50.9% | 1.34% | +57.0% |
| LXFR | Sell | LUXFER HOLDINGS PLC | $46,570,000 | -0.5% | 2,093,024 | -4.9% | 1.32% | -3.4% |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $44,528,000 | -0.5% | 2,593,337 | +29.5% | 1.26% | -3.4% |
| SFT | Sell | SHIFT TECHNOLOGIES INCcl a | $42,917,000 | +3.6% | 5,001,932 | -0.1% | 1.22% | +0.7% |
| DXPE | Buy | DXP ENTERPRISES INC | $42,597,000 | +11.7% | 1,279,183 | +1.2% | 1.21% | +8.6% |
| TDOC | Buy | TELADOC HEALTH INCput | $39,910,000 | +119.6% | 240,000 | +140.0% | 1.13% | +113.6% |
| SBTX | Buy | SILVERBACK THERAPEUTICS INC | $39,115,000 | -8.4% | 1,266,266 | +27.6% | 1.11% | -11.0% |
| TA | Sell | TRAVELCENTERS OF AMERICA INC | $37,746,000 | +7.8% | 1,290,898 | -0.0% | 1.07% | +4.7% |
| GDEN | Sell | GOLDEN ENTMT INC | $32,526,000 | +41.8% | 726,027 | -20.1% | 0.92% | +37.7% |
| CUE | Sell | CUE BIOPHARMA INC | $31,195,000 | -5.4% | 2,677,666 | -1.0% | 0.89% | -8.1% |
| IMTX | Buy | IMMATICS N.V | $29,543,000 | +7.9% | 2,544,622 | +4.2% | 0.84% | +4.9% |
| ALTG | Buy | ALTA EQUIPMENT GROUP INC | $27,302,000 | +3.7% | 2,054,289 | +1.4% | 0.78% | +0.8% |
| FBIO | Sell | FORTRESS BIOTECH INC | $26,879,000 | -11.5% | 7,529,169 | -12.5% | 0.76% | -14.0% |
| IMXI | Buy | INTERNATIONAL MNY EXPRESS IN | $25,575,000 | +12.9% | 1,722,240 | +14.2% | 0.73% | +9.8% |
| RMR | Buy | RMR GROUP INCcl a | $25,540,000 | -3.6% | 660,984 | +1.8% | 0.73% | -6.2% |
| KROS | Buy | KEROS THERAPEUTICS INC | $25,434,000 | -10.2% | 598,880 | +30.1% | 0.72% | -12.7% |
| Sell | APTOSE BIOSCIENCES INC | $25,038,000 | -45.9% | 7,541,497 | -2.6% | 0.71% | -47.4% | |
| MILE | Buy | METROMILE INC | $25,006,000 | -0.1% | 2,732,851 | +12.3% | 0.71% | -3.0% |
| PTON | New | PELOTON INTERACTIVE INCcall | $24,804,000 | – | 200,000 | +100.0% | 0.70% | – |
| MLHR | New | MILLER HERMAN INCcall | $23,570,000 | – | 500,000 | +100.0% | 0.67% | – |
| RDVT | New | RED VIOLET INC | $23,520,000 | – | 1,000,000 | +100.0% | 0.67% | – |
| Buy | DARIOHEALTH CORP | $22,717,000 | +57.2% | 1,063,515 | +41.8% | 0.64% | +52.8% | |
| CERC | Sell | CERECOR INC | $20,685,000 | -10.5% | 6,325,677 | -17.3% | 0.59% | -12.9% |
| BKE | New | BUCKLE INCcall | $19,900,000 | – | 400,000 | +100.0% | 0.56% | – |
| AKBA | Buy | AKEBIA THERAPEUTICS INC | $19,595,000 | +12.4% | 5,170,063 | +0.4% | 0.56% | +9.2% |
| Buy | AKUMIN INC | $19,595,000 | -8.3% | 6,220,740 | +7.7% | 0.56% | -10.7% | |
| PWP | New | PERELLA WEINBERG PARTNERS | $19,431,000 | – | 1,510,996 | +100.0% | 0.55% | – |
| BBQ | New | BBQ HLDGS INC | $18,980,000 | – | 1,000,000 | +100.0% | 0.54% | – |
| PAYO | New | PAYONEER GLOBAL INC | $18,758,000 | – | 1,808,889 | +100.0% | 0.53% | – |
| APEN | Buy | APOLLO ENDOSURGERY INC | $18,772,000 | +49.4% | 2,317,491 | +1.6% | 0.53% | +45.2% |
| SGMS | Sell | SCIENTIFIC GAMES CORP | $18,402,000 | -64.5% | 237,628 | -82.3% | 0.52% | -65.5% |
| SPCE | VIRGIN GALACTIC HOLDINGS INCcall | $18,400,000 | +50.2% | 400,000 | 0.0% | 0.52% | +46.1% | |
| VG | VONAGE HLDGS CORPcall | $18,012,000 | +21.9% | 1,250,000 | 0.0% | 0.51% | +18.5% | |
| CRIS | Buy | CURIS INC | $16,814,000 | -10.7% | 2,083,536 | +25.3% | 0.48% | -13.1% |
| PAYA | Buy | PAYA HOLDINGS INC | $16,465,000 | +7.8% | 1,494,116 | +7.2% | 0.47% | +4.7% |
| RDI | Buy | READING INTL INCcl a | $16,148,000 | +37.3% | 2,316,739 | +9.3% | 0.46% | +33.4% |
| HLF | New | HERBALIFE NUTRITION LTDcall | $14,659,000 | – | 278,000 | +100.0% | 0.42% | – |
| Sell | FALCON MINERALS CORP | $13,344,000 | +10.5% | 2,626,748 | -2.3% | 0.38% | +7.4% | |
| FTCVU | FINTECH ACQUISITION CORP Vunit 99/99/9999 | $13,080,000 | +9.5% | 1,000,000 | 0.0% | 0.37% | +6.6% | |
| IMAX | New | IMAX CORPcall | $12,900,000 | – | 600,000 | +100.0% | 0.37% | – |
| DHX | Sell | DHI GROUP INC | $12,773,000 | -20.7% | 3,778,900 | -21.4% | 0.36% | -22.9% |
| EXAS | Sell | EXACT SCIENCES CORPput | $12,431,000 | -52.8% | 100,000 | -50.0% | 0.35% | -54.2% |
| VMD | Sell | VIEMED HEALTHCARE INC | $12,159,000 | -37.8% | 1,700,596 | -11.9% | 0.34% | -39.6% |
| NAUT | New | NAUTILUS BIOTECHNOLOGY INC | $12,027,000 | – | 1,190,810 | +100.0% | 0.34% | – |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $11,950,000 | -26.1% | 1,794,232 | -37.8% | 0.34% | -28.1% |
| AUTL | New | AUTOLUS THERAPEUTICS PLCspon ads | $11,909,000 | – | 1,793,500 | +100.0% | 0.34% | – |
| AGLE | Sell | AEGLEA BIOTHERAPEUTICS INC | $11,672,000 | -13.9% | 1,677,036 | -2.0% | 0.33% | -16.2% |
| LINC | Sell | LINCOLN EDL SVCS CORP | $11,345,000 | +18.4% | 1,458,208 | -2.4% | 0.32% | +15.0% |
| SLNO | Buy | SOLENO THERAPEUTICS INC | $11,132,000 | +13.0% | 9,765,129 | +24.9% | 0.32% | +9.7% |
| CBIO | Sell | CATALYST BIOSCIENCES INC | $10,961,000 | -15.1% | 2,531,360 | -1.2% | 0.31% | -17.5% |
| PAR TECHNOLOGY CORPnote 2.875% 4/1 | $10,884,000 | +45.0% | 6,000,000 | 0.0% | 0.31% | +41.1% | ||
| HOME | New | AT HOME GROUP INC | $10,499,000 | – | 285,000 | +100.0% | 0.30% | – |
| FTAAU | FTAC ATHENA ACQUISITION CORPunit 99/99/9999 | $10,200,000 | +2.0% | 1,000,000 | 0.0% | 0.29% | -0.7% | |
| FTVIU | New | FINTECH ACQUISITION CORP VIunit 06/24/2026 | $10,090,000 | – | 1,000,000 | +100.0% | 0.29% | – |
| IIIIU | INSU ACQUISITION CORP IIIunit 12/31/2026 | $10,050,000 | -0.5% | 1,000,000 | 0.0% | 0.29% | -3.1% | |
| FTPAU | FTAC PARNASSUS ACQUISITN CORunit 03/10/2026 | $10,050,000 | +1.2% | 1,000,000 | 0.0% | 0.29% | -1.4% | |
| HERAU | FTAC HERA ACQUISITION CORPunit 02/28/2026 | $10,045,000 | +0.6% | 1,000,000 | 0.0% | 0.28% | -2.4% | |
| SRNG | New | SOARING EAGLE ACQUISITION CO | $9,754,000 | – | 979,358 | +100.0% | 0.28% | – |
| SRL | Buy | SCULLY ROYALTY LTD | $9,481,000 | +46.2% | 779,349 | +4.8% | 0.27% | +41.6% |
| PRTY | New | PARTY CITY HOLDCO INCcall | $9,330,000 | – | 1,000,000 | +100.0% | 0.26% | – |
| TSHA | Buy | TAYSHA GENE THERAPIES INC | $9,160,000 | +1121.3% | 432,072 | +1069.2% | 0.26% | +1081.8% |
| ZVO | Buy | ZOVIO INC | $8,136,000 | -35.2% | 3,141,286 | +1.6% | 0.23% | -37.1% |
| CAR | Sell | AVIS BUDGET GROUP | $8,030,000 | -82.2% | 103,100 | -83.5% | 0.23% | -82.8% |
| HCA | HCA HEALTHCARE INC | $7,360,000 | +9.8% | 35,600 | 0.0% | 0.21% | +6.6% | |
| ACAD | ACADIA PHARMACEUTICALS INCcall | $7,317,000 | -5.5% | 300,000 | 0.0% | 0.21% | -8.0% | |
| SSKN | STRATA SKIN SCIENCES INC | $7,151,000 | -6.6% | 4,583,908 | 0.0% | 0.20% | -9.4% | |
| RILY | Sell | B. RILEY FINANCIAL INC | $7,162,000 | +25.1% | 94,858 | -6.6% | 0.20% | +21.6% |
| ZGNX | Sell | ZOGENIX INC | $6,682,000 | -27.6% | 386,696 | -18.3% | 0.19% | -29.6% |
| HARP | Sell | HARPOON THERAPEUTICS INC | $6,148,000 | -35.1% | 443,247 | -2.1% | 0.18% | -36.8% |
| DVD | DOVER MOTORSPORTS INC | $5,843,000 | +9.2% | 2,597,086 | 0.0% | 0.17% | +6.4% | |
| XGN | Sell | EXAGEN INC | $5,515,000 | -15.8% | 367,936 | -1.7% | 0.16% | -17.8% |
| RGS | Buy | REGIS CORP MINNput | $5,148,000 | +2.5% | 550,000 | +37.5% | 0.15% | -0.7% |
| IKNA | Buy | IKENA ONCOLOGY INC | $4,909,000 | -46.5% | 349,660 | +7.6% | 0.14% | -48.1% |
| IMAC | Sell | IMAC HLDGS INC | $4,898,000 | +18.7% | 2,473,637 | -1.1% | 0.14% | +14.9% |
| HOOK | Sell | HOOKIPA PHARMA INC | $4,691,000 | -61.2% | 512,108 | -43.1% | 0.13% | -62.4% |
| ELOX | New | ELOXX PHARMACEUTICALS INC | $4,510,000 | – | 2,266,287 | +100.0% | 0.13% | – |
| ARYD | ARYA SCIENCES ACQU CORP IVcl a | $4,288,000 | +2.4% | 400,000 | 0.0% | 0.12% | 0.0% | |
| LVTX | LAVA THERAPEUTICS NV | $4,148,000 | -28.4% | 381,227 | 0.0% | 0.12% | -30.2% | |
| ROCRU | Sell | ROTH CH ACQUISITION III COunit 02/26/2026 | $4,110,000 | +2.8% | 399,006 | -0.2% | 0.12% | 0.0% |
| BRPMU | B RILEY PRINCIPAL 150 MERGERunit 99/99/9999 | $3,799,000 | +1.3% | 375,000 | 0.0% | 0.11% | -1.8% | |
| MACK | Sell | MERRIMACK PHARMACEUTICALS IN | $3,655,000 | -4.4% | 571,946 | -6.1% | 0.10% | -7.1% |
| TFFP | Sell | TFF PHARMACEUTICALS INC | $3,535,000 | -31.9% | 367,817 | -3.9% | 0.10% | -34.2% |
| NPCE | New | NEUROPACE INC | $3,507,000 | – | 147,404 | +100.0% | 0.10% | – |
| HCAQ | Buy | HEALTHCOR CATALIO ACQU CORP | $3,490,000 | +20.1% | 354,296 | +21.9% | 0.10% | +16.5% |
| ACET | Sell | ADICET BIO INC | $3,195,000 | -38.3% | 310,540 | -21.6% | 0.09% | -39.7% |
| KIRK | New | KIRKLANDS INCput | $3,032,000 | – | 132,500 | +100.0% | 0.09% | – |
| GLMD | Sell | GALMED PHARMACEUTICALS LTD | $2,872,000 | -31.0% | 944,631 | -22.2% | 0.08% | -32.8% |
| ACER | ACER THERAPEUTICS INC | $2,673,000 | -8.0% | 934,755 | 0.0% | 0.08% | -10.6% | |
| HTGM | HTG MOLECULAR DIAGNOSTICS IN | $2,113,000 | +6.2% | 363,622 | 0.0% | 0.06% | +3.4% | |
| FVAM | 5 01 ACQUISITION CORP | $1,861,000 | -0.1% | 186,650 | 0.0% | 0.05% | -1.9% | |
| ANGN | ANGION BIOMEDICA CORP | $1,628,000 | -27.9% | 125,000 | 0.0% | 0.05% | -30.3% | |
| Sell | TELIGENT INC NEW | $1,294,000 | -49.9% | 2,418,987 | -41.8% | 0.04% | -51.3% | |
| MILEW | Buy | METROMILE INC*w exp 02/09/202 | $1,234,000 | -63.8% | 558,296 | +6.3% | 0.04% | -65.0% |
| KTRA | Sell | KINTARA THERAPEUTICS INC | $1,188,000 | -24.4% | 523,279 | -42.0% | 0.03% | -26.1% |
| SOACWS | New | SUSTAINABLE OPPORTNTS ACQ CO*w exp 99/99/999 | $1,156,000 | – | 802,758 | +100.0% | 0.03% | – |
| PWPPW | New | PERELLA WEINBERG PARTNERS*w exp 12/31/202 | $1,112,000 | – | 400,000 | +100.0% | 0.03% | – |
| BOLT | BOLT BIOTHERAPEUTICS INC | $773,000 | -53.0% | 50,000 | 0.0% | 0.02% | -54.2% | |
| PAYOW | New | PAYONEER GLOBAL INC*w exp 06/25/202 | $790,000 | – | 333,327 | +100.0% | 0.02% | – |
| IMTXW | IMMATICS N.V*w exp 07/01/202 | $779,000 | -51.7% | 226,471 | 0.0% | 0.02% | -53.2% | |
| CYRN | CYREN LTD | $485,000 | -0.4% | 598,540 | 0.0% | 0.01% | 0.0% | |
| MDIA | MEDIACO HLDG INCcl a | $373,000 | +7.8% | 103,680 | 0.0% | 0.01% | +10.0% | |
| SIGA | Sell | SIGA TECHNOLOGIES INC | $312,000 | -54.2% | 49,605 | -52.6% | 0.01% | -55.0% |
| FALCON MINERALS CORP*w exp 07/21/202 | $167,000 | -76.6% | 878,022 | 0.0% | 0.01% | -76.2% | ||
| ATXI | AVENUE THERAPEUTICS INC | $76,000 | -58.5% | 30,211 | 0.0% | 0.00% | -60.0% | |
| THC | Exit | TENET HEALTHCARE CORP | $0 | – | -16,408 | -100.0% | -0.02% | – |
| AAN | Exit | THE AARONS COMPANY INC | $0 | – | -35,026 | -100.0% | -0.03% | – |
| SIC | Exit | SELECT INTERIOR CONCEPTS INCcl a | $0 | – | -156,573 | -100.0% | -0.03% | – |
| CDXS | Exit | CODEXIS INCcall | $0 | – | -53,700 | -100.0% | -0.04% | – |
| ALTGWS | Exit | ALTA EQUIPMENT GROUP INC*w exp 02/14/202 | $0 | – | -179,300 | -100.0% | -0.05% | – |
| CELC | Exit | CELCUITY INC | $0 | – | -133,367 | -100.0% | -0.06% | – |
| BCTG | Exit | BCTG ACQUISITION CORP | $0 | – | -175,915 | -100.0% | -0.06% | – |
| FTOCW | Exit | FTAC OLYMPUS ACQUISITION COR*w exp 08/28/202 | $0 | – | -333,327 | -100.0% | -0.06% | – |
| TBBK | Exit | BANCORP INC DEL | $0 | – | -139,629 | -100.0% | -0.08% | – |
| AFI | Exit | ARMSTRONG FLOORING INC | $0 | – | -609,349 | -100.0% | -0.09% | – |
| SFT | Exit | SHIFT TECHNOLOGIES INCcall | $0 | – | -400,000 | -100.0% | -0.10% | – |
| ARYA | Exit | ARYA SCIENCES ACQUISITION CO | $0 | – | -706,770 | -100.0% | -0.28% | – |
| FTIVU | Exit | FINTECH ACQUISITION CORP IVunit 12/31/2025 | $0 | – | -1,200,000 | -100.0% | -0.40% | – |
| FTOC | Exit | FTAC OLYMPUS ACQUISITION COR | $0 | – | -1,508,889 | -100.0% | -0.47% | – |
| EHTH | Exit | EHEALTH INC | $0 | – | -280,562 | -100.0% | -0.60% | – |
| ARKG | Exit | ARK ETF TRcall | $0 | – | -500,000 | -100.0% | -1.30% | – |
| IWM | Exit | ISHARES TRrussell 2000 etf | $0 | – | -273,745 | -100.0% | -1.77% | – |
| IWM | Exit | ISHARES TRcall | $0 | – | -400,000 | -100.0% | -2.58% | – |
| QQQ | Exit | INVESCO QQQ TRput | $0 | – | -600,000 | -100.0% | -5.60% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
About Nantahala Capital Management
Nantahala Capital Management is a hedge fund that was founded in 2004 by Wil Harkey. The firm is headquartered in Connecticut and has additional offices in New York and North Carolina. Nantahala Capital Management primarily invests in the technology, healthcare, and consumer sectors. The firm has a long-term investment approach and seeks to identify undervalued companies with strong growth potential.
Wil Harkey serves as the CEO and Chief Investment Officer of Nantahala Capital Management. He has over 20 years of experience in the finance industry and previously worked at Goldman Sachs and Maverick Capital. In addition to Harkey, the firm's leadership team includes COO and General Counsel, David Kozak, and CFO, Michael Kozak.
Nantahala Capital Management has a strong track record of generating positive returns for its investors. The firm's flagship fund, the Nantahala Fund, has delivered an annualized return of over 20% since its inception in 2006. The firm's success can be attributed to its disciplined investment approach and focus on long-term value creation.
Overall, Nantahala Capital Management is a well-respected hedge fund with a talented leadership team and a strong track record of performance. However, as with any investment, it is important for investors to conduct their own due diligence and carefully consider the risks before investing in the firm's funds.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 42 | Q3 2023 | 27.2% |
| CODEXIS INC | 42 | Q3 2023 | 3.9% |
| PATHWARD FINANCIAL INC | 35 | Q3 2023 | 6.3% |
| SCIENTIFIC GAMES CORP | 34 | Q3 2022 | 5.3% |
| DOVER MOTORSPORTS INC | 34 | Q3 2021 | 0.5% |
| GOLDEN ENTMT INC | 33 | Q3 2023 | 2.1% |
| QAD INC | 32 | Q3 2021 | 2.6% |
| SCIENTIFIC GAMES CORP | 31 | Q4 2021 | 7.7% |
| DOLBY LABORATORIES INC | 31 | Q4 2020 | 5.6% |
| LINCOLN EDL SVCS CORP | 31 | Q4 2021 | 0.7% |
View Nantahala Capital Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AYTU BIOPHARMA, INC | June 16, 2023 | 1,086,812 | 19.7% |
| Acer Therapeutics Inc. | February 14, 2023 | 1,226,191 | 7.5% |
| Aeglea BioTherapeutics, Inc. | February 14, 2023 | 4,611,302 | 7.5% |
| AKUMIN INC. | February 14, 2023 | 2,206,960 | 2.5% |
| ALTA EQUIPMENT GROUP INC. | February 14, 2023 | 1,188,985 | 3.7% |
| Apollo Endosurgery, Inc. | February 14, 2023 | 4,056,627 | 9.9% |
| Autolus Therapeutics plc | February 14, 2023 | 7,782,018 | 4.7% |
| Bioventus Inc. | February 14, 2023 | 3,168,574 | 5.1% |
| CATALYST BIOSCIENCES, INC. | February 14, 2023 | 438,055 | 1.4% |
| Drive Shack Inc. | February 14, 2023 | 6,500,000 | 7.0% |
View Nantahala Capital Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-21 |
| 4 | 2024-03-15 |
| SC 13G | 2024-03-11 |
| 13F-HR/A | 2024-02-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Nantahala Capital Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.